7th Aug 2024
Jefferies maintains Neuren Pharma at 'buy' with a price target of A$29.75
An analyst from Jefferies maintained Neuren Pharma (ASX: NEU) at 'buy' with a price target of A$29.750 from a prior price target of A$31.400. Prior to this rating, Neuren Pharma had 6 buy ratings, 0 hold ratings, and 0 sell ratings. Neuren Pharma's stock price closed at A$17.09. They are down -12.360% in the last month and up 41.830% in the last 12 months.
Link to full article:
https://www.investing.com/news/pro/neuren-fpo-receives-investment-bank-analyst-rating-update-3558434
Ann: Q2 2024 update, page-43
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.02 |
Change
0.080(0.62%) |
Mkt cap ! $1.664B | |||
| Open | High | Low | Value | Volume |
| $13.23 | $13.35 | $12.99 | $5.557M | 423.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1588 | $13.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.06 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |